<DOC>
	<DOCNO>NCT00880672</DOCNO>
	<brief_summary>The purpose study determine whether dutasteride may influence expression angiogenesis factor hypoxia inducible factor ( HIF ) -1alpha vascular endothelial growth factor ( VEGF ) patient low urinary tract symptoms/benign prostatic hyperplasia ( LUTS/BPH ) .</brief_summary>
	<brief_title>Effect Dutasteride HIF-1alpha VEGF Prostate</brief_title>
	<detailed_description>A total 41 patient await transurethral resection prostate ( TURP ) divide two group ( 1:1 ) ; twenty patient receive medication 21 receive 0.5 mg dutasteride daily 2 4 week TURP . In group , extent , intensity intracellular location hypoxia inducible factor ( HIF ) -1alpha vascular endothelial growth factor ( VEGF ) evaluate . Microvessel density also compare two group .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>inform consent 50 year old old International Prostate Symptom Score ( IPSS ) &gt; 8 Maximum flow rate ( Qmax ) &lt; 15 ml/s transurethral resection prostate ( TURP ) urethral catheter urinary tract infection ( UTI ) liver disease renal disease unexplained hematuria prostate specific antigen ( PSA ) &gt; 4ng/ml ( include prostate biopsy negative ) interstitial cystitis bladder cancer prostate cancer pelvic surgery irradiation</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>prostate , dutasteride</keyword>
	<keyword>vascular endothelial growth factor</keyword>
	<keyword>hypoxia inducible factor</keyword>
</DOC>